Search for: "ROCHE"
Results 1 - 20
of 1,883
Sorted by Relevance
|
Sort by Date
5 Aug 2008, 4:34 pm
Meanwhile, Roche Chairman Franz Humer has reportedly [...] [read post]
20 Mar 2008, 10:01 pm
Roche then proposed royalty payments of 20% to Amgen which they rejected. [read post]
15 Oct 2009, 9:52 pm
Ranbaxy's arguments of invalidity of the Roche claims were rejected.Valganciclovir (Roche's Valcyte) is considered the most effective antiviral treatment for cytomegalovirus retinitis among HIV patients. [read post]
27 Jun 2019, 6:33 am
Was Roche shielding? [read post]
10 Oct 2018, 6:47 pm
Roche lost.Appellant Roche Molecular Systems, Inc. [read post]
22 Jan 2008, 9:16 pm
By Donald Zuhn -- Roche announced today that it had signed a definitive merger agreement with Ventana Medical Systems. [read post]
31 Jan 2009, 6:32 am
Roche already owns 54 percent of the stock. [read post]
25 Jul 2008, 12:08 pm
Sanders, called Roche's offer "unsolicited and unexpected. [read post]
13 Aug 2008, 3:03 pm
In rebuffing Roche’s $89-per-share offer for the 44 percent of Genentech it doesn’t already own, [...] [read post]
26 Sep 2007, 4:11 am
Roche’s bid values the company at about $3 billion. [read post]
27 Jun 2007, 9:01 pm
Today, Roche announced that it has commenced a cash tender offer for all outstanding shares of Ventana common... [read post]
9 Jul 2007, 8:16 pm
The agreement includes an upfront payment of $331 million from Roche to Alnylam, which includes cash payments, purchase... [read post]
27 Jan 2012, 7:33 am
Illumina said on Friday that its board would review Roche's unsolicited $5.7 billion offer. [read post]
16 Mar 2009, 2:36 am
from GEN: Roche is taking over innovatis, a provider of automated cell analysis solutions, for ââ [read post]
13 Mar 2009, 2:54 pm
Roche has held a majority ownership interest in Genentech for some time. [read post]
27 Jan 2012, 9:19 am
Roche said on Friday that it had begun its unsolicited tender offer of $44.50 a share in cash for the shares of Illumina. [read post]
10 Jul 2007, 8:17 pm
In the past week, however, it appears that Roche's acquisition of Ventana may have hit a snag -... [read post]
21 Jul 2008, 1:50 pm
Will Roche need to dig deeper to win Genentech? [read post]
12 Oct 2017, 4:53 pm
-based Biogen is entitled to between 13.5 and 24 percent of U.S. sales and 3 percent of sales elsewhere from Roche’s new multiple sclerosis drug Ocrevus, whose annual revenue may hit $4 billion by 2022.from Double Whammy for Roche See also previous IPBiz post:Lipoic acid and secondary progressive multiple sclerosis [read post]
12 Aug 2010, 4:33 am
O'Neill's case against Roche Diagnostics was filed in Feburary in federal court in Illinois, but in late July was moved, at Roche's request, to federal court in Indianapolis. [read post]
